Whitney & Co’s GSK GSK Stock Holding History

Whitney & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-319	Closed	-$16K	–	246
2018 Q3	$16K	Buy	319 +239	+299%	+$12.1K	﹤0.01%	267
2018 Q2	$4K	Sell	80 -960	-92%	-$48.4K	﹤0.01%	275
2018 Q1	$51K	Buy	+1,040	New	+$48.4K	0.01%	172

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Whitney & Co's GSK Position: Q4 2018 in Review

Whitney & Co sold out of GSK (GSK) in Q4 2018, closing a stake of 319 shares — an estimated $16K sold.

Whitney & Co first reported a position in GSK in Q1 2018 and held it in 3 quarters. The position peaked at $51K in Q1 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Whitney & Co reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 319 GSK shares in Q4 2018, an estimated $16K.
Whitney & Co first reported a position in GSK in Q1 2018 and held it in 3 quarters.
Whitney & Co's GSK position peaked at $51K in Q1 2018.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.